Cramer backs Medline, AST SpaceMobile; NuScale too speculative
Jim Cramer endorsed Medline Inc. as the best IPO of the year and called AST SpaceMobile, Inc. a speculative buy ahead of satellite launches. He labeled NuScale Power Corporation too speculative, preferring GE Vernova Inc.

*this image is generated using AI for illustrative purposes only.
On CNBC’s Mad Money Lightning Round, Jim Cramer endorsed Medline Inc. (NASDAQ: MDLN), calling it probably the best IPO of the year. Medline is scheduled to report second-quarter financial results on Wednesday, Aug. 5, with analysts expecting earnings of 32 cents per share on revenue of $7.52 billion. The stock gained 5.8% to close at $41.73.
Cramer also expressed support for AST SpaceMobile, Inc. (NASDAQ: ASTS), describing it as a great speculative stock with potential returns in two years. The company announced that its next three BlueBird satellites are targeted to launch aboard a Falcon 9 rocket from Cape Canaveral, Florida, in the first half of August to expand its space-based cellular broadband network. AST SpaceMobile shares fell 3.1% to settle at $86.10.
Regarding the power sector, Cramer stated that NuScale Power Corporation (NYSE: SMR) is too speculative for his taste, preferring GE Vernova Inc. (NYSE: GEV) as a safer alternative. NuScale Power will review second-quarter results on Wednesday, Aug. 5, with analysts projecting a loss of 13 cents per share on revenue of $14.71 million. NuScale shares gained 1.2% to settle at $10.15.
Price Action Summary
| Asset | Price Movement | Closing Price |
|---|---|---|
| Medline Inc. | Gained 5.8% | $41.73 |
| NuScale Power Corporation | Gained 1.2% | $10.15 |
| AST SpaceMobile, Inc. | Fell 3.1% | $86.10 |
Will Medline's upcoming earnings report validate Cramer's 'best IPO' endorsement and sustain the stock's recent momentum?
Can AST SpaceMobile successfully execute its August satellite launches to achieve the two-term returns Cramer projected?
Will NuScale Power's earnings report reveal enough progress to overcome Cramer's concerns about its speculative nature?

































